MUSC clinical trial testing device showing promise to cure heart failure

An ongoing trial at the Medical University of South Carolina is looking for a breakthrough for patients dealing with heart ...
Pharmabiz

Bayer receives Japanese approval for finerenone to treat patients with chronic heart failure

Bayer receives Japanese approval for finerenone to treat patients with chronic heart failure: Berlin Tuesday, December 23, 2025, 14:00 Hrs [IST] Bayer announced that Japan’s Min ...
Healio

GLP-1s show benefit in heart failure, but monitor, manage heart rate

GLP-1s improved outcomes in patients with heart failure with preserved ejection fraction, with or without obesity, but those ...
Becker's ASC

How AI might solve gender disparities in this specialty

The American Heart Association’s Go Red for Women Venture Fund has invested in Ultrom=nics, an AI-driven cardiology solutions developer, to enhance early identification of heart failure, Fem Tech ...

Recreational marathoners show no long-term heart damage after 10 years

A collaboration of researchers in Switzerland, Germany, and the US tracked cardiac function in recreational marathon runners ...
The New England Journal of Medicine

Semaglutide in Patients with Obesity-Related Heart Failure and Type 2 Diabetes

Obesity and type 2 diabetes are prevalent in patients with heart failure with preserved ejection fraction and are characterized by a high symptom burden. No approved therapies specifically target ...
CNN

New heart failure guidelines add another type of meds to treatment recommendations

The American College of Cardiology, the American Heart Association and the Heart Failure Society of America released new guidelines Friday that add a fourth class of medication to the recommended ...